These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
541 related articles for article (PubMed ID: 15833846)
21. Modulation of 5-fluorouracil resistance in human colon tumor cell lines by azidothymidine. Findenig G; Mader RM; Fritzer-Szekeres M; Steger GG; Jaeger W; Szekeres T Oncol Res; 1996; 8(5):189-96. PubMed ID: 8884811 [TBL] [Abstract][Full Text] [Related]
22. Down regulation of c-Myc and induction of an angiogenesis inhibitor, thrombospondin-1, by 5-FU in human colon cancer KM12C cells. Zhao HY; Ooyama A; Yamamoto M; Ikeda R; Haraguchi M; Tabata S; Furukawa T; Che XF; Iwashita K; Oka T; Fukushima M; Nakagawa M; Ono M; Kuwano M; Akiyama S Cancer Lett; 2008 Oct; 270(1):156-63. PubMed ID: 18583030 [TBL] [Abstract][Full Text] [Related]
23. Mechanistic and predictive profiling of 5-Fluorouracil resistance in human cancer cells. Wang W; Cassidy J; O'Brien V; Ryan KM; Collie-Duguid E Cancer Res; 2004 Nov; 64(22):8167-76. PubMed ID: 15548681 [TBL] [Abstract][Full Text] [Related]
24. Metabotropic glutamate receptor 4-mediated 5-Fluorouracil resistance in a human colon cancer cell line. Yoo BC; Jeon E; Hong SH; Shin YK; Chang HJ; Park JG Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4176-84. PubMed ID: 15217955 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of the p38 MAPK pathway sensitises human colon cancer cells to 5-fluorouracil treatment. Yang SY; Miah A; Sales KM; Fuller B; Seifalian AM; Winslet M Int J Oncol; 2011 Jun; 38(6):1695-702. PubMed ID: 21424124 [TBL] [Abstract][Full Text] [Related]
26. Efficient execution of cell death in non-glycolytic cells requires the generation of ROS controlled by the activity of mitochondrial H+-ATP synthase. Santamaría G; Martínez-Diez M; Fabregat I; Cuezva JM Carcinogenesis; 2006 May; 27(5):925-35. PubMed ID: 16361271 [TBL] [Abstract][Full Text] [Related]
27. Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment. Adamsen BL; Kravik KL; Clausen OP; De Angelis PM Int J Oncol; 2007 Dec; 31(6):1491-500. PubMed ID: 17982676 [TBL] [Abstract][Full Text] [Related]
28. Pharmacological profile of the selective mitochondrial F1F0 ATP hydrolase inhibitor BMS-199264 in myocardial ischemia. Grover GJ; Malm J Cardiovasc Ther; 2008; 26(4):287-96. PubMed ID: 19035880 [TBL] [Abstract][Full Text] [Related]
29. Combining siRNAs at two different sites in the EGFR to suppress its expression, induce apoptosis, and enhance 5-fluorouracil sensitivity of colon cancer cells. Wu X; Deng Y; Wang G; Tao K J Surg Res; 2007 Mar; 138(1):56-63. PubMed ID: 17169374 [TBL] [Abstract][Full Text] [Related]
30. Energetic signalling in the control of mitochondrial F1F0 ATP synthase activity in health and disease. Grover GJ; Marone PA; Koetzner L; Seto-Young D Int J Biochem Cell Biol; 2008; 40(12):2698-701. PubMed ID: 18707016 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells. Li J; Hou N; Faried A; Tsutsumi S; Takeuchi T; Kuwano H Ann Surg Oncol; 2009 Mar; 16(3):761-71. PubMed ID: 19116755 [TBL] [Abstract][Full Text] [Related]
32. Drug efflux transporter multidrug resistance-associated protein 5 affects sensitivity of pancreatic cancer cell lines to the nucleoside anticancer drug 5-fluorouracil. Nambaru PK; Hübner T; Köck K; Mews S; Grube M; Payen L; Guitton J; Sendler M; Jedlitschky G; Rimmbach C; Rosskopf D; Kowalczyk DW; Kroemer HK; Weiss FU; Mayerle J; Lerch MM; Ritter CA Drug Metab Dispos; 2011 Jan; 39(1):132-9. PubMed ID: 20930123 [TBL] [Abstract][Full Text] [Related]
33. Silencing hexokinase II gene sensitizes human colon cancer cells to 5-fluorouracil. Peng Q; Zhou J; Zhou Q; Pan F; Zhong D; Liang H Hepatogastroenterology; 2009; 56(90):355-60. PubMed ID: 19579598 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signaling. Ischenko I; Camaj P; Seeliger H; Kleespies A; Guba M; De Toni EN; Schwarz B; Graeb C; Eichhorn ME; Jauch KW; Bruns CJ Oncogene; 2008 Dec; 27(57):7212-22. PubMed ID: 18794807 [TBL] [Abstract][Full Text] [Related]
35. Atypical subunit composition of the chlorophycean mitochondrial F1FO-ATP synthase and role of Asa7 protein in stability and oligomycin resistance of the enzyme. Lapaille M; Escobar-Ramírez A; Degand H; Baurain D; Rodríguez-Salinas E; Coosemans N; Boutry M; Gonzalez-Halphen D; Remacle C; Cardol P Mol Biol Evol; 2010 Jul; 27(7):1630-44. PubMed ID: 20156838 [TBL] [Abstract][Full Text] [Related]
36. Nifedipine synergizes with calcium in activating the calcium sensing receptor, suppressing the expression of thymidylate synthase and survivin and promoting sensitivity to fluorouracil in human colon carcinoma cells. Liu G; Hu X; Premkumar L; Chakrabarty S Mol Carcinog; 2011 Dec; 50(12):922-30. PubMed ID: 21374737 [TBL] [Abstract][Full Text] [Related]
37. The β6-integrin-ERK/MAP kinase pathway contributes to chemo resistance in colon cancer. Liu S; Wang J; Niu W; Liu E; Wang J; Peng C; Lin P; Wang B; Khan AQ; Gao H; Liang B; Shahbaz M; Niu J Cancer Lett; 2013 Jan; 328(2):325-34. PubMed ID: 23073477 [TBL] [Abstract][Full Text] [Related]
38. CDK inhibitor enhances the sensitivity to 5-fluorouracil in colorectal cancer cells. Takagi K; Sowa Y; Cevik OM; Nakanishi R; Sakai T Int J Oncol; 2008 May; 32(5):1105-10. PubMed ID: 18425338 [TBL] [Abstract][Full Text] [Related]
39. Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer. Ahn JY; Lee JS; Min HY; Lee HY Oncotarget; 2015 Oct; 6(32):32622-33. PubMed ID: 26416450 [TBL] [Abstract][Full Text] [Related]
40. Synergism between a siRNA targeted to survivin and 5-FU in inhibiting MCF-7 cell proliferation in vitro. Zhang SQ; Zhang SH; Xue XH; Wang XJ; Jiang JT Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):251-4. PubMed ID: 16546719 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]